Harrow Inc (HROW) FY2025Q2 Earning Prediction

08/11 04:00:00

After Hours

Harrow Inc (HROW) is set to release its earnings performance on 08/11 04:00:00 in After Hours trading. Consensus forecasts predict a revenue of 66.03M and an earnings per share (EPS) of 0.00 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!

Estimate

Actual

Surprise

RevenueMISS

66.03M

63.74M

-3.47%

EPS-

0.00

0.24

Slide

Earnings Surprise Analysis

The chart displays the extent of earnings surprises and corresponding stock price movements for each earnings event.

Revenue

EPS

HROW Transcript

Harrow, Inc. (HROW) Q3 2025 Earnings Call Transcript

Positive11-11

The earnings call summary and Q&A highlight strong product development and market strategy, especially with VEVYE's market penetration and new PBM coverage. Although there are concerns regarding ASP decline and inventory shortages, the overall sentiment is positive due to expected revenue growth, strategic expansions, and leverage on SG&A. The positive guidance and strategic market moves outweigh the potential risks, leading to a likely positive stock price movement.

Harrow, Inc. (HROW) Q2 2025 Earnings Call Transcript

Positive8-12

The earnings call summary indicates strong growth in key revenue segments like IHEEZO and TRIESENCE, with positive guidance for the future. Despite a decline in VEVYE revenue, prescription volumes are up, and ASPs are expected to rise. The Q&A section reveals management's confidence in growth strategies and upcoming launches, although some uncertainty remains around biosimilar timing. Overall, the positive growth outlook and strategic initiatives suggest a likely positive stock price movement.

Harrow, Inc. (HROW) Q3 2024 Earnings Call Transcript

Neutral11-14

The earnings call presents a strong financial performance with record revenue growth and optimistic future guidance. The Q&A section reinforces positive sentiment with strong demand for TRIESENCE and VEVYE, despite minor disruptions. The lack of share repurchase announcements and some regulatory risks are potential concerns, but the overall outlook with strategic agreements and market expansion is favorable. The absence of market cap data suggests a moderate impact on stock price, leading to a positive prediction.

Harrow, Inc. (HROW) Q2 2024 Earnings Call Transcript

Positive8-8

The earnings call reveals strong financial performance, with a 46% YoY revenue increase, and strategic growth in VEVYE and IHEEZO. Despite risks in FDA approvals and market competition, the company shows robust market access and prescription growth. The lack of a share buyback program is a minor negative, but the overall sentiment is positive due to strong financial metrics and optimistic guidance for 2024.

HROW Slides

Harrow Health Q2 2025 slides: Mixed results amid strategic portfolio expansion

2025-08-11

HROW Report

Frequently Asked Questions

What is the Harrow Inc FY2025Q2 Earnings Release Date and Time?

Harrow Inc (HROW) is scheduled to release its FY2025Q2 earnings report onAug 11, 2025, After Hours(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.

What Are the Consensus Forecasts for Harrow Inc FY2025Q2 Revenue and EPS?

Analysts' consensus predicts 66.03M in revenue and an EPS of 0.00 for Harrow Inc's FY2025Q2.

What Does Intellectia's AI Predict for Harrow Inc FY2025Q2 Earnings?

Intellectia's exclusive AI algorithms forecast a forHarrow Inc's FY2025Q2 earnings, with a prediction date of Aug 11, 2025. Harrow Inc

How Can I Use This Earnings Prediction to Trade HROW Stock?

Leverage Intellectia's AI forecast to position trades ahead of theAug 11, 2025 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.

How Accurate Is Intellectia's AI for Earnings Predictions Like Harrow Inc FY2025Q2?

Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.

How does AI Earnings Prediction generate its forecasts?

AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!

When are the predictions available, and how often are they updated?

Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.

Can I use AI Earnings Prediction for all types of stocks?

Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2024-2025 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!